Tiziana Life Sciences Ownership 2024 | Who Owns Tiziana Life Sciences Now?
Institutional Ownership
0.00%
Insider Ownership
38.17%
Retail Ownership
61.83%
Institutional Holders
1.00
Tiziana Life Sciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.11% | 4,589 | 4,589 | 100.00% | 309,000 | Jun 30, 2024 |
Tiziana Life Sciences's largest institutional shareholder is ALPHAMARK ADVISORS, LLC, holding 0.00% of the company's total share outstanding, currently valued at $309.00K. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.11% | 4,589 | 4,589 | 100.00% | 309,000 | Jun 30, 2024 |
The largest Tiziana Life Sciences shareholder by % of total assets is ALPHAMARK ADVISORS, LLC. The company owns 4.59K shares of Tiziana Life Sciences (TLSA), representing 0.11% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.11% | 4,589 | 4,589 | 100.00% | 309,000 | Jun 30, 2024 |
As of Jun 30 2024, Tiziana Life Sciences's largest institutional buyer is ALPHAMARK ADVISORS, LLC. The company purchased 4.59K stocks of TLSA, valued at $309.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.11% | 4,589 | 4,589 | 100.00% | 309,000 | Jun 30, 2024 |
As of Jun 30 2024, Tiziana Life Sciences's biggest institutional seller is ALPHAMARK ADVISORS, LLC. The company sold 4.59K shares of TLSA, valued at $309.00K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALPHAMARK ADVISORS, LLC | 0.00% | 0.11% | 4,589 | 4,589 | 100.00% | 309,000 | Jun 30, 2024 |
Tiziana Life Sciences's largest new institutional shareholder by number of shares is ALPHAMARK ADVISORS, LLC, purchased 4.59K shares, valued at $309.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Tiziana Life Sciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY COMMONWEALTH TRUST | 0.04% | 117,651 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 282,875 | - | - | Mar 31, 2024 |
| TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 54,218 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 14,852 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 553,692 | - | - | Mar 31, 2024 |
Tiziana Life Sciences's largest mutual fund holder by % of total assets is "FIDELITY COMMONWEALTH TRUST", owning 117.65K shares, compromising 0.04% of its total assets.
Tiziana Life Sciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | - |
| 30 Sep, 21 | 21 | 5.00% |
| 30 Jun, 21 | 20 | -23.08% |
| 31 Mar, 21 | 26 | 13.04% |
| 31 Dec, 20 | 23 | 4.55% |
| 30 Sep, 20 | 22 | 120.00% |
| 30 Jun, 20 | 10 | 66.67% |
| 31 Mar, 20 | 6 | 20.00% |
| 31 Dec, 19 | 5 | 25.00% |
| 30 Sep, 19 | 4 | 33.33% |
| 30 Jun, 19 | 3 | -25.00% |
| 31 Mar, 19 | 4 | 100.00% |
| 31 Dec, 18 | 2 | - |
As of 30 Jun 24, 1 institutions are holding Tiziana Life Sciences's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,589 | - |
| 30 Sep, 21 | 1,398,352 | -74.91% |
| 30 Jun, 21 | 5,573,024 | 9.25% |
| 31 Mar, 21 | 5,101,379 | -19.81% |
| 31 Dec, 20 | 6,361,551 | 27.36% |
| 30 Sep, 20 | 4,995,131 | 251.59% |
| 30 Jun, 20 | 1,420,707 | 17.15% |
| 31 Mar, 20 | 1,212,699 | -2.86% |
| 31 Dec, 19 | 1,248,392 | 101.58% |
| 30 Sep, 19 | 619,290 | 3.18% |
| 30 Jun, 19 | 600,188 | -2.45% |
| 31 Mar, 19 | 615,259 | 59.69% |
| 31 Dec, 18 | 385,274 | - |
Tiziana Life Sciences (TLSA) has 4.59K shares outstanding as of 30 Jun 24, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 0.00% | - |
| 30 Sep, 21 | 1.44% | 4.38% |
| 30 Jun, 21 | 5.73% | 20.84% |
| 31 Mar, 21 | 5.24% | 12.27% |
| 31 Dec, 20 | 6.54% | 24.81% |
| 30 Sep, 20 | 5.13% | 38.53% |
| 30 Jun, 20 | 3.65% | 37.60% |
| 31 Mar, 20 | 3.12% | 30.29% |
| 31 Dec, 19 | 3.21% | 31.67% |
| 30 Sep, 19 | 3.18% | 33.46% |
| 30 Jun, 19 | 3.08% | 30.86% |
| 31 Mar, 19 | 3.16% | 80.66% |
| 31 Dec, 18 | 1.98% | - |
As of 30 Jun 24, Tiziana Life Sciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 30 Sep 21.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 1 | - |
| 30 Sep, 21 | 13 | 18.18% |
| 30 Jun, 21 | 11 | -35.29% |
| 31 Mar, 21 | 17 | 13.33% |
| 31 Dec, 20 | 15 | -21.05% |
| 30 Sep, 20 | 19 | 216.67% |
| 30 Jun, 20 | 6 | 100.00% |
| 31 Mar, 20 | 3 | -40.00% |
| 31 Dec, 19 | 5 | 66.67% |
| 30 Sep, 19 | 3 | 200.00% |
| 30 Jun, 19 | 1 | -66.67% |
| 31 Mar, 19 | 3 | 50.00% |
| 31 Dec, 18 | 2 | - |
1 institutional shareholders have increased their position in TLSA stock as of 30 Jun 24 compared to 13 in the previous quarter (a 0.00% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | - | - |
| 30 Sep, 21 | 4 | -33.33% |
| 30 Jun, 21 | 6 | 200.00% |
| 31 Mar, 21 | 2 | -66.67% |
| 31 Dec, 20 | 6 | 200.00% |
| 30 Sep, 20 | 2 | 100.00% |
| 30 Jun, 20 | 1 | -50.00% |
| 31 Mar, 20 | 2 | - |
| 31 Dec, 19 | - | -100.00% |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | 1 | - |
| 31 Dec, 18 | - | - |
- institutional shareholders have reduced their position in TLSA stock as of 30 Jun 24 compared to 4 in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 1 | - | 4,589 | - | 0.00% | - | 1 | - | - | - |
| 30 Sep, 21 | 21 | 5.00% | 1,398,352 | -74.91% | 1.44% | 4.38% | 13 | 18.18% | 4 | -33.33% |
| 30 Jun, 21 | 20 | -23.08% | 5,573,024 | 9.25% | 5.73% | 20.84% | 11 | -35.29% | 6 | 200.00% |
| 31 Mar, 21 | 26 | 13.04% | 5,101,379 | -19.81% | 5.24% | 12.27% | 17 | 13.33% | 2 | -66.67% |
| 31 Dec, 20 | 23 | 4.55% | 6,361,551 | 27.36% | 6.54% | 24.81% | 15 | -21.05% | 6 | 200.00% |
| 30 Sep, 20 | 22 | 120.00% | 4,995,131 | 251.59% | 5.13% | 38.53% | 19 | 216.67% | 2 | 100.00% |
| 30 Jun, 20 | 10 | 66.67% | 1,420,707 | 17.15% | 3.65% | 37.60% | 6 | 100.00% | 1 | -50.00% |
| 31 Mar, 20 | 6 | 20.00% | 1,212,699 | -2.86% | 3.12% | 30.29% | 3 | -40.00% | 2 | - |
| 31 Dec, 19 | 5 | 25.00% | 1,248,392 | 101.58% | 3.21% | 31.67% | 5 | 66.67% | - | -100.00% |
| 30 Sep, 19 | 4 | 33.33% | 619,290 | 3.18% | 3.18% | 33.46% | 3 | 200.00% | 1 | - |
| 30 Jun, 19 | 3 | -25.00% | 600,188 | -2.45% | 3.08% | 30.86% | 1 | -66.67% | 1 | - |
| 31 Mar, 19 | 4 | 100.00% | 615,259 | 59.69% | 3.16% | 80.66% | 3 | 50.00% | 1 | - |
| 31 Dec, 18 | 2 | - | 385,274 | - | 1.98% | - | 2 | - | - | - |
Tiziana Life Sciences Peer Ownership
| Ticker | Company |
|---|---|
| MGTA | Dianthus Therapeutics, Inc. |
| SPRC | SciSparc Ltd. |
| INBX | Inhibrx, Inc. |
| ADAP | Adaptimmune Therapeutics plc |
| QNRX | Quoin Pharmaceuticals, Ltd. |
| CRVS | Corvus Pharmaceuticals, Inc. |
| BHVN | Biohaven Pharmaceutical Holding Company Ltd. |
| APTO | Aptose Biosciences Inc. |
| HILS | Tharimmune, Inc. |
| CMND | Clearmind Medicine Inc. |
| AFMD | Affimed N.V. |
| BNOX | Bionomics Limited |
| LPTX | Leap Therapeutics, Inc. |
| IMNM | Immunome, Inc. |
TLSA Ownership FAQ
Who Owns Tiziana Life Sciences?
Tiziana Life Sciences is owned by institutional shareholders (0.00%), insiders (38.17%), and public (61.83%). The largest institutional shareholder of Tiziana Life Sciences is ALPHAMARK ADVISORS, LLC (0.00% of total shares) and the top mutual fund owner is FIDELITY COMMONWEALTH TRUST (0.04% of total shares).
Who are the major institutional shareholders of Tiziana Life Sciences?
Tiziana Life Sciences's major institutional shareholders are ALPHAMARK ADVISORS, LLC. The top five shareholders own together 0.00% of the company's share outstanding.
How many Tiziana Life Sciences shareholders are there?
As of Jun 2024, there are 1 institutional shareholders of Tiziana Life Sciences.
What percentage of Tiziana Life Sciences is owned by ALPHAMARK ADVISORS, LLC?
ALPHAMARK ADVISORS, LLC owns 4.59K shares of Tiziana Life Sciences, representing 0.00% of the company's total shares outstanding, valued at $309K (as of Jun 2024).